tiprankstipranks
Trending News
More News >
Gilead Sciences (GILD)
NASDAQ:GILD
US Market

Gilead Sciences (GILD) Ratios

Compare
13,764 Followers

Gilead Sciences Ratios

GILD's free cash flow for Q3 2025 was $0.80. For the 2025 fiscal year, GILD's free cash flow was decreased by $ and operating cash flow was $0.50. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.45 1.60 1.43 1.29 1.27
Quick Ratio
1.31 1.45 1.27 1.15 1.13
Cash Ratio
0.60 0.83 0.54 0.48 0.46
Solvency Ratio
0.29 0.08 0.21 0.16 0.18
Operating Cash Flow Ratio
0.79 0.90 0.71 0.81 0.98
Short-Term Operating Cash Flow Coverage
3.45 5.97 4.45 3.99 7.51
Net Current Asset Value
$ -19.20B$ -20.58B$ -23.29B$ -27.52B$ -32.12B
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.45 0.40 0.40 0.39
Debt-to-Equity Ratio
1.16 1.38 1.09 1.19 1.27
Debt-to-Capital Ratio
0.54 0.58 0.52 0.54 0.56
Long-Term Debt-to-Capital Ratio
0.51 0.56 0.50 0.52 0.54
Financial Leverage Ratio
2.72 3.05 2.72 2.97 3.23
Debt Service Coverage Ratio
3.11 1.51 3.37 2.37 3.68
Interest Coverage Ratio
10.29 1.70 8.06 7.84 9.91
Debt to Market Cap
0.13 0.23 0.25 0.23 0.29
Interest Debt Per Share
20.88 22.20 20.78 20.85 22.05
Net Debt to EBITDA
1.29 3.77 1.80 2.24 1.89
Profitability Margins
Gross Profit Margin
78.71%78.26%76.04%79.26%75.82%
EBIT Margin
37.49%5.80%28.78%24.74%33.98%
EBITDA Margin
47.00%15.42%38.71%32.45%41.49%
Operating Profit Margin
36.07%5.78%28.05%26.87%36.32%
Pretax Profit Margin
33.99%2.40%25.30%21.31%30.32%
Net Profit Margin
27.88%1.67%20.89%16.83%22.80%
Continuous Operations Profit Margin
27.88%1.67%20.70%16.74%22.71%
Net Income Per EBT
82.04%69.57%82.59%78.98%75.20%
EBT Per EBIT
94.24%41.52%90.19%79.32%83.46%
Return on Assets (ROA)
13.86%0.81%9.12%7.27%9.16%
Return on Equity (ROE)
40.70%2.48%24.81%21.62%29.55%
Return on Capital Employed (ROCE)
22.69%3.54%14.96%14.11%17.60%
Return on Invested Capital (ROIC)
17.55%2.36%11.82%10.62%12.84%
Return on Tangible Assets
25.15%1.56%20.71%17.69%23.79%
Earnings Yield
4.37%0.42%5.60%4.26%6.83%
Efficiency Ratios
Receivables Turnover
5.71 6.51 5.82 5.71 6.08
Payables Turnover
7.66 7.50 11.81 6.25 9.36
Inventory Turnover
3.47 3.66 3.64 3.75 4.08
Fixed Asset Turnover
5.29 5.31 5.10 4.98 5.33
Asset Turnover
0.50 0.49 0.44 0.43 0.40
Working Capital Turnover Ratio
6.39 4.80 6.77 8.57 7.04
Cash Conversion Cycle
121.54 107.32 132.21 102.75 110.54
Days of Sales Outstanding
63.94 56.11 62.73 63.91 60.06
Days of Inventory Outstanding
105.24 99.85 100.38 97.23 89.47
Days of Payables Outstanding
47.64 48.64 30.89 58.39 38.98
Operating Cycle
169.17 155.96 163.10 161.15 149.53
Cash Flow Ratios
Operating Cash Flow Per Share
7.78 8.68 6.42 7.23 9.06
Free Cash Flow Per Share
7.37 8.26 5.95 6.65 8.60
CapEx Per Share
0.41 0.42 0.47 0.58 0.46
Free Cash Flow to Operating Cash Flow
0.95 0.95 0.93 0.92 0.95
Dividend Paid and CapEx Coverage Ratio
2.15 2.44 1.82 2.04 2.72
Capital Expenditure Coverage Ratio
19.14 20.70 13.69 12.46 19.66
Operating Cash Flow Coverage Ratio
0.39 0.41 0.32 0.36 0.43
Operating Cash Flow to Sales Ratio
0.33 0.38 0.30 0.33 0.42
Free Cash Flow Yield
4.94%8.95%7.34%7.74%11.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.89 239.97 17.85 23.46 14.65
Price-to-Sales (P/S) Ratio
6.37 4.01 3.73 3.95 3.34
Price-to-Book (P/B) Ratio
8.62 5.96 4.43 5.07 4.33
Price-to-Free Cash Flow (P/FCF) Ratio
20.23 11.18 13.62 12.91 8.44
Price-to-Operating Cash Flow Ratio
19.21 10.64 12.63 11.88 8.01
Price-to-Earnings Growth (PEG) Ratio
0.79 -2.62 0.74 -0.90 <0.01
Price-to-Fair Value
8.62 5.96 4.43 5.07 4.33
Enterprise Value Multiple
14.84 29.75 11.43 14.41 9.94
Enterprise Value
202.93B 131.91B 120.00B 127.56B 112.56B
EV to EBITDA
14.84 29.75 11.43 14.41 9.94
EV to Sales
6.98 4.59 4.43 4.68 4.12
EV to Free Cash Flow
22.15 12.80 16.17 15.29 10.42
EV to Operating Cash Flow
20.99 12.18 14.99 14.06 9.89
Tangible Book Value Per Share
-3.88 -7.23 -9.63 -12.75 -16.50
Shareholders’ Equity Per Share
17.33 15.50 18.30 16.92 16.77
Tax and Other Ratios
Effective Tax Rate
0.18 0.31 0.18 0.21 0.25
Revenue Per Share
23.40 23.06 21.73 21.74 21.74
Net Income Per Share
6.52 0.38 4.54 3.66 4.96
Tax Burden
0.82 0.70 0.83 0.79 0.75
Interest Burden
0.91 0.41 0.88 0.86 0.89
Research & Development to Revenue
0.20 0.21 0.21 0.18 0.17
SG&A to Revenue
0.07 0.09 0.10 0.18 0.17
Stock-Based Compensation to Revenue
0.03 0.03 0.03 0.02 0.02
Income Quality
1.19 22.56 1.41 1.98 1.84
Currency in USD